Pricing Log in Create free account

Codexis, Inc. (CDXS) vs Cue Biopharma, Inc. (CUE)

Codexis, Inc. and Cue Biopharma, Inc. are both Biotechnology companies. Codexis, Inc. and Cue Biopharma, Inc. are of similar size ($148.9M and $135.6M). Cue Biopharma, Inc. grew revenue faster over the last twelve months: 354.4% against 35.9%. Codexis, Inc. has the higher net margin (−39.6% vs −435.8%) and the lower return on invested capital (−151.2% vs 0.00%). Across the 18 metrics below, Codexis, Inc. leads on 11 and Cue Biopharma, Inc. on 7.

Valuation

Metric CDXS CUE Biotechnology median
P/E n/m n/m 8.42
P/S 1.58 3.14 10.01
P/B 3.73 51.25 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 1.31 2.73 9.41
Earnings yield (25.19%) (144.73%) (31.85%)
Free cash flow yield (9.90%) (42.34%) (24.58%)

Profitability

Metric CDXS CUE Biotechnology median
Gross margin 87.02% 100.00% 65.16%
Operating margin (35.61%) (262.03%) 0.00%
Net margin (39.55%) (435.83%) 0.00%
Free cash flow margin (15.66%) (133.13%) 0.00%
Return on equity (69.36%) (1,603.48%) (56.36%)
Return on assets (23.79%) (459.60%) (48.04%)
Return on invested capital (151.17%) 0.00% 0.00%

Growth

Metric CDXS CUE Biotechnology median
Revenue growth (TTM) 35.89% 354.37% 6.02%
EPS growth (last fiscal year) 43.82% 61.11% 30.26%
Revenue growth, 5-year CAGR 0.38% 54.16% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS CUE Biotechnology median
Debt to equity 1.03 0.00 0.00
Current ratio 3.06 1.25 4.72
Net debt to EBITDA 1.11 1.10 0.96

Dividend

Metric CDXS CUE Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CDXS CUE Biotechnology median
Market cap 148.93m 135.63m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack